Bicatero 50, Bicalutamide, AntiCancer Drugs, Hormones & Menopausal, Online Pharmacy, ZarvyPharm
AntiCancer Drugs HORMONES Antiandrogenic drugs Prostate Cancer

Bicatero 50 Tablet

★★★★★
★★★★★
0

(0)

Generic For CASODEX
Active Ingredient BICALUTAMIDE
Strength 50MG
Manufacturer HETERO DRUGS
Bicatero 50 box, front-facing view with product name and 10 TABLETS label visible
Bicatero 50 blister pack beside box, tablets exposed and packaging details legible
Bicatero 50 box, top-side shot with label readable
Bicatero 50 box, front-facing view with product name and 10 TABLETS label visible
Bicatero 50 blister pack beside box, tablets exposed and packaging details legible
Bicatero 50 box, top-side shot with label readable
Best available coupon applied for preview!
Use code ZARVY26 at checkout to get 15% OFF your order.
COUPON CODE
ZARVY26
15% OFF
Pack Size Price Per Unit Unit Price QTY CART Best Coupon Price
MAX DISCOUNT
3 BOXES - 30 TABLETS $ 0.69 $ 20.65
$ 17.55
Apply ZARVY26 (-15%)
You save $ 3.10
6 BOXES - 60 TABLETS $ 0.61
11% $ 41.30
$ 36.65
$ 31.15
Apply ZARVY26 (-15%)
You save $ 5.50
★ Best Value 9 BOXES - 90 TABLETS $ 0.57
17% $ 61.95
$ 51.45
$ 43.73
Apply ZARVY26 (-15%)
You save $ 7.72

Exchange & Returns Information

 

 

Reference

Reference information will be available soon.

Product Description

Bicatero 50 contains bicalutamide 50 mg, a non-steroidal androgen receptor antagonist used as part of combination androgen-deprivation therapy (ADT) for advanced/metastatic prostate cancer. Bicalutamide competitively blocks androgen receptors in prostate tissue, preventing testosterone/DHT from stimulating tumor growth.

Available through trusted online pharmacy channels, Bicatero 50 is commonly prescribed once daily alongside LHRH analogs (e.g., leuprolide, goserelin) to achieve complete peripheral androgen blockade and slow disease progression.

Indications & Uses

  • AntiCancer Drugs | Prostate Cancer
    Adjunctive therapy for Stage D2 / metastatic prostate carcinoma in combination with LHRH agonists/analogs.
    Used to reduce androgen-driven tumor activity, achieve PSA declines and symptom control when combined therapy is indicated.
  • Note: Not indicated as standalone curative treatment; use per oncology/urology guidance.

Benefits & Effectiveness

  • Bicalutamide blocks androgen receptor activation in target tissues, neutralizing testosterone/DHT effects and reducing prostate cancer cell proliferation signals.
  • When started with LHRH analogs, contributes to earlier PSA reduction and symptomatic stabilization.
  • Oral once-daily dosing supports adherence and outpatient management; generally well tolerated compared with older steroidal agents.

Directions for Use

  • Dose: 50 mg orally once daily (same time each day).
  • Administration: with or without food; swallow whole with water.
  • Combination: initiate concurrently with LHRH analog therapy to ensure complete androgen blockade.
  • Duration: typically long-term depending on clinical response and tolerability; follow oncologist/urologist instructions.
  • Missed dose: skip missed dose and resume next scheduled dose — do not double.
  • Monitoring: regular PSA and liver function tests (LFTs); assess symptoms, bone health and sexual function as appropriate.

Storage

  • Store at 15–25°C in a dry place, protected from light and moisture. Keep in original packaging and out of reach of children.

Possible Side Effects

  • Common: gynecomastia, breast tenderness, hot flashes, fatigue, nausea.
  • Hormonal/sexual: decreased libido, erectile dysfunction.
  • Rare but serious: elevated liver enzymes, cholestatic hepatitis, interstitial pneumonitis.
  • Action: monitor LFTs; stop and investigate if jaundice, severe abdominal pain, or respiratory symptoms occur.

FAQs

Yes, bicalutamide can be taken with or without food. Try to take it at the same time each day for consistency.
Sudden discontinuation may reduce treatment effectiveness. Always consult your physician before altering your treatment plan.
No, bicalutamide does not lower testosterone production directly. It blocks testosterone from binding to its receptors in prostate tissue.
Duration depends on disease response. It is typically taken long-term in metastatic cases alongside other hormonal agents.
No, it is a hormone therapy agent, not a cytotoxic chemotherapy. It works by altering hormonal pathways rather than killing cells directly.

Ratings & Reviews

Reviewed by 0 Users

0/5
★★★★★
★★★★★
5★
0%
4★
0%
3★
0%
2★
0%
1★
0%

Write a Review:

✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.

✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.

💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.


Multiple orders:

✓ If you bought this product more than once on different days, you can write a separate review for each order.

💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.

Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.

No reviews yet. Be the first to review this product!

Alternatives

Combo Deals

No combo deals available at the moment.